Joyce Wu

Ms. Joyce Wu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JWJoyce Wu
Joyce Wu
AAAhmed M. Afifi
Ahmed M. Afifi
HXHong Xie
Hong Xie
LMLila E. Mahmoud
Lila E. Mahmoud
SASulaiman Aldoohan
Sulaiman Aldoohan
SGStephen r Grider
Stephen r Grider
Background: Mild traumatic brain injury (mTBI) may rapidly alter neurocognitive function and has been associated with an increased risk for post-traumatic stress disorder (PTSD). However, neuroimaging investigations during the acute post-trauma phase remain sparse. We previously reported greater left anterior insular cortex (aIC) activation during the cognitive appraisal of fearful versus neutral emotional faces in survivors who did and did not exhibit probable PTSD at 3 months, but not at 2 weeks, after a motor vehicle collision (MVC). Given previous studies suggesting that mTBI may lead to increased cortical activation in the early post-trauma period, we hypothesize that aIC activation within 2 weeks post-MVC may be elevated among probable PTSD survivors who sustained an mTBI compared to those who did not sustain mTBI. Methods: In this secondary hypothesis-driven analysis, previously reported task-related activation at both 2 weeks and 3 months after trauma was extracted from the aIC region of interest and compared among groups of survivors diagnosed with probable PTSD at 3 months with (n = 5) and without (n = 11) mTBI in the emergency department. An exploratory analysis of change over time included two time points and additional groups of survivors without probable PTSD with (n = 10) and without (n = 12) mTBI. Results: At 2 weeks, aIC activation was significantly greater in the probable PTSD with mTBI group than in the probable PTSD without mTBI group (mean = 0.125, SD = 0.053 vs. 0.014, SD = 0.111) (Welch’s t (13.86) = 2.71, two-sided p = 0.017). aIC activation in probable PTSD survivors with and without mTBI was not significantly different at 3 months after MVC. The time and time × group interactions were not significant in brain activation and post-traumatic stress symptoms, but within-group tests suggest that decreases in post-traumatic stress symptoms over time were significant in groups without mTBI. Conclusions: These preliminary results are consistent with the hypothesized association between mTBI and greater aIC activation to negative emotional stimuli in the early post-trauma period among survivors with probable PTSD, but do not support post-trauma brain changes in survivors with mTBI, probable PTSD, both conditions, or neither condition. These preliminary findings warrant further investigation into the relationship between mTBI and probable PTSD-related cortical alterations during the acute post-trauma period.

16 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
AOAzeezat Oluwatobiloba Osikoya
Azeezat Oluwatobiloba Osikoya
SSShobhit Srivastava
Shobhit Srivastava
DTDavid Terrero
David Terrero
JWJoyce Wu
Joyce Wu
LLLeah Caroline Lorenz
Leah Caroline Lorenz
DRDayanidhi Raman
Dayanidhi Raman
BC (BC) stemness contributes to aggressive primary tumor progression and increased propensity for metastasis. Additionally, BC stem-like cells (BCSCs) immensely contribute to drug resistance and relapse. Knowing the biological attributes of BCSCs is vital to employ efficacious therapies against them. In this review, we aim to cover the intrinsic characteristics of BCSCs, the autocrine signaling and paracrine activation by the available cytokines in the tumor microenvironment (TME) and opportunities for targeted therapies both intrinsic and extrinsic to BCSCs. Salient actionable molecular targets and vulnerabilities within the BCSCs and their surrounding bulk tumor and stromal cell compartments in triple-negative breast (TNBC) will be mostly discussed. Enhanced knowledge regarding the BCSCs and their microenvironment will enable us to effectively treat late stage and refractory BC.